Emplicure’s CEO presents the company on two occasions in March
2022-03-10 08:50
Emplicure's CEO Torbjörn W. Larsson will present the company on two separate occasions in March, at Aktiespararna and BioStock.
Monday March 14, 2022, at 12:00 – Aktiedagen Stockholm
The presentationen can be streamed live or on demand via the Aktiespararna YouTube-channel or aktiespararna.se/tv/live.
Questions during the live stream can be asked via text message to +46 79-347 98 45 or via email to event@aktiespararna.se
Wednesday March 16, 2022 at 11:45 – BioStock Investor Meeting
The presentationen can be streamed live or on demand via the BioStock YouTube-channel
or via BioStock Investor Meeting
For more information, please contact:
Torbjörn W. Larsson
VD
Phone: +46 (0)70 747 65 99
Email: twl@emplicure.com
Erik Magnusson
CFO, Investor Relations
Phone: +46 (0)708 565 245
Email: erik.magnusson@emplicure.com
Certified Adviser
Mangold Fondkommission AB
Phone: +46 (0)8 5030 1550, or ca@mangold.se
The following documents can be retrieved from beQuoted
PM-Emplicures-CEO-presents-the-company-on-two-occasions.pdf
Emplicure is a pharmaceutical company developing new and innovative drugs by combining existing and approved active substances, and advanced materials science within ceramic biomaterials. The product portfolio is focused on chronic pain, and with abuse deterrent formulations. The wholly owned subisidiary, Amplicon AB develops consumer products, with tobacco-free nicotine as the first product. Read more at www.emplicure.com